How do antacids containing aluminium and magnesium hydroxide affect rosuvastatin plasma concentrations?

Simultaneous dosing with an antacid suspension containing aluminium and magnesium hydroxide decreases rosuvastatin plasma concentrations by approximately 50%; this effect is reduced when the antacid is taken two hours after rosuvastatin, and its clinical relevance has not been studied.